Peter O. Hofgaard

Institute for Transfusion Medicine — United States

Immunology and Microbiology · Life Sciences

15h-index1.3kcitations36works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(27), CAR-T cell therapy research(19), Monoclonal and Polyclonal Antibodies Research(15), T-cell and B-cell Immunology(11), Immune Cell Function and Interaction(7)

Publications36 total

Abstract C057: Tankyrase Inhibition Reprograms Melanoma Metastases to Overcome Resistance to PD-1 Blockade

Cancer Immunology Research·2026

Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM

1 cited

Journal for ImmunoTherapy of Cancer·2023· 1 citedOpen Access

Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma

9 cited

Pharmaceutics·2023· 9 citedOpen Access

Supplementary Figure 1 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 2 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 4 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 3 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 2 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Table 2 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 4 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Table 2 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Data from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Table 1 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 1 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Table 1 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Data from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Supplementary Figure 3 from Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

2023Open Access

Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice

17 cited

Leukemia·2017· 17 citedOpen Access

Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma

96 cited

Journal of Clinical Investigation·2015· 96 citedOpen Access

Idiotype-specific CD4+ T cells eradicate disseminated myeloma

21 cited

Leukemia·2015· 21 cited

page 1 of 2Next →

Frequent Co-authors

Bjarne Bogen(28), Alexandre Corthay(19), Katrin U. Lundin(18), Kristina Berg Lorvik(16), Hilde Omholt(8), Ludvig A. Munthe(4), Zlatko Dembić(4), Karl Schenck(4), Anders Tveita(3), Grete F. Lauritzsen(3), Bjarne Bogen(3), Ole Audun Werner Haabeth(2), Marte Fauskanger(2), Fredrik Schjesvold(2), Jiro Kikuchi(2), Daisuke Koyama(2), Taeko Wada(2), Tohru Izumi(2), Yusuke Furukawa(2), Olav Schreurs(2)